Skip to content
Storytelling Co – Lifestyle
Author:
Alpha-9 Oncology
Alpha-9 Oncology Announces Presentation of Data for its GRPR-Targeting Imaging Compound ⁶⁸Ga-A9-6217 at the European Association of Nuclear Medicine (EANM) 2026 Annual Congress
October 13, 2026
Alpha-9 Oncology Doses First Patient in GRPR-Targeted Radiotherapeutics Trial
September 8, 2026